Novel biomarkers are being discovered using TISSUEFAXS CHROMA and StrataQuest image analysis solution, with promising candidates used for predicting a patient’s response to neoadjuvant treatment of rectal cancer. A recent study demonstrated that the equal weighing of two separate quantifications of Type 1 interferon (IFN) expression and CD8+ T cell density can predict the chances of patients displaying a pathological complete response to neoadjuvant treatment of rectal adenocarcinoma. The scale and treatment of rectal adenocarcinoma Rectal cancer is one of the most common types of cancer worldwide, and it is the third most common type of cancer in women and…